News FDA Qualifies First AI-Powered Tool for Use in MASH Clinical TrialsHealthradar10. Dezember 2025 What You Should Know: – PathAI has secured a historic regulatory milestone with the FDA qualification of its AIM-MASH AI…
Health Welldoc Expands AI-Powered Cardiometabolic Platform to Include Chronic Kidney Disease and MASH SupportHealthradar21. Oktober 2025 The AI-powered platform elevates cardiometabolic care by extending its best-in-class weight management support to CKD and MASH. COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®,…
